Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

US Patent 10959988 · Granted Mar 30, 2021

Estimated economic value: $34,272,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl compounds for treating Huntington's disease2024
Compounds for treating huntington's disease2024
Heterocyclic and heteroaryl compounds for treating Huntington's disease2024
Compounds for treating Huntington's disease2023
Methods for treating Huntington's disease2023
Substituted reverse pyrimidine Bmi-1 inhibitors2021
Processes for the preparation of substituted tetrahydro beta-carbolines2021
Processes for the preparation of substituted tetrahydro beta-carbolines2021
Processes for the preparation of substituted tetrahydro beta-carbolines2021
Methods for treating Huntington's disease2021
Methods for treating Huntington's disease2020
Substituted pyridine and pyrazine BMI-1 inhibitors2020